Egd: Clinical Trials

2 trials of Egd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Egd: new trials by email Literature Review of Egd trials Research Report on Egd

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GCC Agonist Signal in the Small Intestine
Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy - Barrett Esophagus, Gastroesophageal Reflux Disease
Phase 1CompletedUniversity of Wisconsin, Madison432022-11-302026-04-07
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Atezolizumab, Bevacizumab, External Beam Radiation Therapy - Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic852019-09-192026-10-05

Conditions studied

Barrett Esophagus (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Gastroesophageal Reflux (1)  ·  Gastrointestinal Neoplasms (1)

Sponsors

Mayo Clinic (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (2)

Top investigators

David S Weinberg (1)  ·  Lewis R. Roberts, MD, PhD (1)  ·  Lionel Kankeu Fonkoua, MD (1)

NIH funding

P30CA014520 (1), R01CA274985 (1), R01CA294704 (1), UG1CA242635 (1)